InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Fromkin Andrew J., Director. Insider active across 1 companies, notably Immunovant, Inc.. Aggregated, 6 reports have been published. Total volume traded: €846k. The latest transaction was disclosed on 1 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
US$385,97019,351 shares@ US$19.94580.0069% mcap91.2% of flow
Common Stock
SEC:0001764013-25-000160·
€385,97019,351 shares@ €19.94580.0069% mcap45.6% of flow
Common Stock
SEC:0001764013-25-000160:0·
021,726 shares0
Common Stock
SEC:0001764013-22-000021·
021,726 shares0
Common Stock
SEC:0001764013-22-000021:0·
€37,0635,500 shares@ €6.73870.0007% mcap8.8% of flow
Common Stock
SEC:0001764013-21-000081·
Ideal exit: 7 May 2022 (T+270)
€37,0635,500 shares@ €6.73870.0007% mcap4.4% of flow
Common Stock
SEC:0001764013-21-000081:0·
Ideal exit: 7 May 2022 (T+270)
6 of 6 declarations
About Fromkin Andrew J.
Andrew J. Fromkin is a Director at Immunovant, Inc. As a board member, he contributes to the governance of the company, providing his expertise and strategic advice. His role is essential in guiding Immunovant's decisions and initiatives.
